Spectrin, Beta, Non-erythrocytic 2 (SPTBN2) (AA 2300-2390), (C-Term) Antikörper
Kurzübersicht für Spectrin, Beta, Non-erythrocytic 2 (SPTBN2) (AA 2300-2390), (C-Term) Antikörper (ABIN363600)
Target
Alle Spectrin, Beta, Non-erythrocytic 2 (SPTBN2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2300-2390, C-Term
-
Spezifität
- Reacts with human SPTBN2 protein
-
Kreuzreaktivität
- Maus
-
Kreuzreaktivität (Details)
- Cross reacts with mouse and rat. Not tested in other species.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- The epitope recognized by this antibody maps to a C-terminal region between residue 2300 and 2390 of human spectrin, beta, non-erythrocytic 2 (spinocerebellar ataxia 5 )
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 10 to 20 μg/mL - IP : 2 to 5 μg/mg lysate - WB : 1/2 000 to 1/10 000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Tris-citrate, phosphate, ( pH 7-8) buffer, Sodium azide 0.09 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
-
- Spectrin, Beta, Non-erythrocytic 2 (SPTBN2)
-
Pathways
- Regulation of Actin Filament Polymerization, Synaptic Vesicle Exocytosis
Target
-